Literature DB >> 30411430

Paediatric immunisation and chemoprophylaxis in a Ugandan sickle cell disease clinic.

Chung-Jen Chen1, Sabrina Bakeera-Kitaka2, Ezekiel Mupere2, Philip Kasirye2, Deogratias Munube2, Richard Idro2, Heather Hume3, Betsy Pfeffer1, Philip LaRussa1, Nancy S Green1.   

Abstract

AIM: We aimed to assess the receipt of recommended care for young children with sickle cell disease (SCD) in a central SCD clinic in Kampala Uganda, focusing on standard vaccination and antibacterial and antimalarial prophylaxis.
METHODS: A cross-sectional assessment of immunisation status and timeliness and prescribed antibacterial and antimalarial prophylaxis was performed in a sample with SCD aged ≤71 months in Mulago Hospital SCD Clinic. Government-issued immunisation cards and clinic-issued visit records for prescribed prophylaxis were reviewed.
RESULTS: Vaccinations were documented by immunisation cards in 104 patients, mean age 31.7 months (range 3-70 months). Only 48 (46.2%) received all doses of each of the four recommended vaccine types, including pneumococcal 10-valent conjugate vaccine (pneumococcal conjugate vaccine (PCV)-10), which became available in 2014. Vaccination completion was associated with younger age and, for polio, maternal employment. PCV-10 series was completed in 54.8% of the sample and in 18.2% of those aged 48-71 months. Of children completing all vaccination types, an average 68.8% were immunised on time, defined as <60 days beyond the recommended age. Only 17 (13.5%) children were both fully and timely vaccinated. In an overlapping sample of 147 children, with a mean age of 38.4 months (4-70 months), 81.6% had ≥1 documented prescription for penicillin and/or antimalarial prophylaxis.
CONCLUSIONS: Standardised vaccination and antibacterial and antimalarial protective measures for young children at this central SCD clinic were incomplete, especially PCV-10 for age ≥24 months, and often late. Child age, but not general maternal demographics, were associated with vaccination and chemoprophylaxis. Clinic-based oversight may improve timely uptake of these preventative measures.
© 2018 Paediatrics and Child Health Division (The Royal Australasian College of Physicians).

Entities:  

Keywords:  haematology; immunisation; international child health; sickle cell disease

Year:  2018        PMID: 30411430      PMCID: PMC6509021          DOI: 10.1111/jpc.14291

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  23 in total

1.  Timeliness of childhood vaccinations in 31 low and middle-income countries.

Authors:  Manas K Akmatov; Rafael T Mikolajczyk
Journal:  J Epidemiol Community Health       Date:  2011-05-06       Impact factor: 3.710

2.  Prevalence of daily medication adherence among children with sickle cell disease: a 1-year retrospective cohort analysis.

Authors:  Niti G Patel; Terianne Lindsey; Robert C Strunk; Michael R DeBaun
Journal:  Pediatr Blood Cancer       Date:  2010-09       Impact factor: 3.167

3.  [Sickle cell disease in children in Dakar, Senegal].

Authors:  I Diagne; O Ndiaye; C Moreira; H Signate-Sy; B Camara; S Diouf; A Diack-Mbaye; M Ba; M Sarr; D Sow; M Fall
Journal:  Arch Pediatr       Date:  2000-01       Impact factor: 1.180

4.  Pneumococcal bacteremia in a vaccinated pediatric sickle cell disease population.

Authors:  Angela M Ellison; Kaede V Ota; Karin L McGowan; Kim Smith-Whitley
Journal:  Pediatr Infect Dis J       Date:  2012-05       Impact factor: 2.129

Review 5.  Increased risk of invasive bacterial infections in African people with sickle-cell disease: a systematic review and meta-analysis.

Authors:  Meenakshi Ramakrishnan; Jennifer C Moïsi; Keith P Klugman; Jesus M Feris Iglesias; Lindsay R Grant; Mireille Mpoudi-Etame; Orin S Levine
Journal:  Lancet Infect Dis       Date:  2010-05       Impact factor: 25.071

Review 6.  Pneumococcal vaccines for sickle cell disease.

Authors:  E G Davies; C Riddington; R Lottenberg; N Dower
Journal:  Cochrane Database Syst Rev       Date:  2004

7.  A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola.

Authors:  Patrick T McGann; Margaret G Ferris; Uma Ramamurthy; Brigida Santos; Vysolela de Oliveira; Luis Bernardino; Russell E Ware
Journal:  Am J Hematol       Date:  2013-10-15       Impact factor: 10.047

8.  Timeliness of childhood vaccinations in Kampala Uganda: a community-based cross-sectional study.

Authors:  Juliet N Babirye; Ingunn M S Engebretsen; Frederick Makumbi; Lars T Fadnes; Henry Wamani; Thorkild Tylleskar; Fred Nuwaha
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

9.  Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study.

Authors:  Thomas N Williams; Sophie Uyoga; Alex Macharia; Carolyne Ndila; Charlotte F McAuley; Daniel H Opi; Salim Mwarumba; Julie Makani; Albert Komba; Moses N Ndiritu; Shahnaaz K Sharif; Kevin Marsh; James A Berkley; J Anthony G Scott
Journal:  Lancet       Date:  2009-09-09       Impact factor: 79.321

10.  Factors influencing childhood immunization in Uganda.

Authors:  Edward Bbaale
Journal:  J Health Popul Nutr       Date:  2013-03       Impact factor: 2.000

View more
  1 in total

Review 1.  Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review.

Authors:  Shannon E MacDonald; Airlie Palichuk; Linda Slater; Hailey Tripp; Laura Reifferscheid; Catherine Burton
Journal:  Hum Vaccin Immunother       Date:  2021-07-16       Impact factor: 3.452

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.